KLWA
GWPH

Kelly Lawrence W & Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Kelly Lawrence W & Associates’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-115
Closed -$25K – 160
2021
Q1 		$25K Buy
+115
New +$21.6K 0.01% 130
2020
Q4 		– Sell
-115
Closed -$11K – 125
2020
Q3 		$11K Hold
115
– – ﹤0.01% 118
2020
Q2 		$14K Hold
115
– – ﹤0.01% 112
2020
Q1 		$10K Hold
115
– – ﹤0.01% 114
2019
Q4 		$12K Hold
115
– – ﹤0.01% 125
2019
Q3 		$13K Hold
115
– – ﹤0.01% 126
2019
Q2 		$20K Buy
+115
New +$19.9K ﹤0.01% 120

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Kelly Lawrence W & Associates's GWPH Position: Q2 2021 in Review

Kelly Lawrence W & Associates sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 115 shares — an estimated $25K sold.

Kelly Lawrence W & Associates first reported a position in GWPH in Q2 2019 and held it in 7 quarters. The position peaked at $25K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Kelly Lawrence W & Associates reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Kelly Lawrence W & Associates sold 115 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $25K.
  • Kelly Lawrence W & Associates first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2019 and held it in 7 quarters.
  • Kelly Lawrence W & Associates's GW Pharmaceuticals Plc American Depositary Shares position peaked at $25K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2021, filed 16 Aug 2021.